On-Demand Virtual Sessions

Nitrosamine Impurities in API & Pharma Products, how to deal?

Understanding the Global Regulatory Perspective to tackle the Nitrosamines in Drug Substances and Drug Products

Quantitative Analysis of In Vivo Mutagenicity Dose-Response Data for Risk Assessment and Regulatory Decision-making: A Case Study of Alkylnitrosamines

Introduction to Nitrosamines Impurities CPhi Conferences Informa

Role of European Pharmacopoeia to Combat Nitrosamine Impurities:

Cloud strategies for better digital transformation

Towards a responsible use of Artificial Intelligence

Risk Management of Potential Nitrosamine Impurities in Commercial and Pipeline Products

Regulatory ICH M7 Update to Identify, Qualify and Safety Assessment of Nitrosamines

Risk Assessment: A Unique Strategy to Avoid Nitrosamines

More than just wrapping a pill: improving patients’ lives through packaging Session

FluroTec™ Barrier Film-Coated Stoppers for your Novel Drug

Use of Pre-filled Syringe (PFS) System help to Reduce Medical Errors

Doing It Right the First Time, Every Time

A Holistic Systems Approach to the Production of API’s and Diverse Applications of Flow Chemistry

Use of Advanced Analytics and AI for Drug Repurposing and Regulatory Affairs

Comprehending the Benefits and Opportunities of Continuous Manufacturing (CM)

How Backward Integrated should your Pharmaceutical Manufacturing Process be to Ensure Quality, Security of Supply and Competitive Cost of Product?

Impurity profiling and risk assessment

Use of Mass Spec Analysis in Product Release Analysis

Consumer & product centric packaging Innopack Pharma Confex

Focus on Medical Devices & Packaging

Instrument Automation for Maximum Efficiency During COVID-19 Crisis

Regulatory system strengthening - A global perspective

Transformation with digital workforce

Analytical Method Development and Quantification of Nitrosamine Impurities in API

India Future Power-Horse of KSMs and API''s as a Backward Integration for Formulations to Propel Exports to US 50  Billion Dollar by 2030- Role R&D, Chemistry & Biology

Overview of the Process Innovation in NDDS

Clinical Studies in Establishing Proof of Concept for NDDS

Integrated Bottling Centers: Intelligent and Future Ready

Recent Innovations in Blister Packaging Technology

Use of Sustainable Chemistry for the Innovation in the Processes of API

Strategic Elements and Practical Aspects of Rolling out HPAPI Projects

Green Chemistry and Noncovalent Derivatization

Towards a Greener Lab and Sustainability: What, Why and How?

Cyclo Olefin Polymer (COP) Pre-filled Syringe Applications

Highlighting the Importance of AI and Robotics in Healthcare and Pharma Packaging

Interchangeability and adaptation in biosimilar development: Where do we stand?

Workshop - Holistic Innovation in Circular Economy Environment

Is Nano the Way Forward for Prevention, Diagnosis and Therapy?

Integrating Serialization in Packaging Operations to Ensure Efficiency in Supply Chain

A Digital Future for Value Added Medicines

Enabling Smart Packaging for Pharma through Printable and Flexible Hybrid Electronics

Is it the Time for People to Mandate QbD in Formulations?

Cold Chain Logistics in the Current Environmen

Current Disruptions in the Supply Chain and understand the Importance of Standardization

Stepping up the Product Value Chain with Innovations in Packaging

The evolving regulatory landscape of USA

Pharma regulatory practices and beyond in Africa

Panel Session – From 4G to 5G – Challenges and opportunities

Panel Session – SDN and NFV enabled next generation packet transport networks

Panel session - From Virtualization to Cloudification – Network transformation

Approval process on biopharma products in EU and UK

Measurement of Safety Performance and its impact on Safety Standards

Biopharma growth & regulatory perspectives in India

Regulatory responses to the Pandemic

Keys to successful third-party operations management

cGMP and GDP global regulatory perspective and way forward

Embracing RIMS in Times of Remote Collaboration!

Regulatory challenges in particle analysis process

Nitrosamines – How to address the unwelcome guests in the pharmaceutical world

Regulation of APIs in Brazil

UK and EU regulatory authority: How to best prepare and perform

Process Safety, Industrial hygiene and Hazard Management

Reinventing The Wheel Through Super Generics With 505(b)(2)

Journey to Success: Strategic Regulatory Partnerships Key Highlights

Electronic product information for human medicines in the EU

Key regulatory considerations for Japan market

Changing face of legislation/ policy – globalization

Biopharma Webinar Series - VACCINE

Workshop - Connected Devices

Biopharma webinar series - Biosimilars

Workshop - Brand Protection and Material Selection

Strategies to implement a successful serialization program

Keynote: PAT Leading to Pharma 4.0 or Vice Versa

Panel Session – How telcos and ISP are playing important role during pandemic

Regulatory Expectations and Understanding of Bioanalytical Data Integrity View of Regulations

Challenges & Opportunities in Understanding Structure Function Relationship in Biologics/Biosimilar Characterization

Multisizer 4e- the Legend of Universal Particle Counting and Sizing

Structural Characterization of the Therapeutic Proteins Using Mass Spectroscopy

Analysis of Host Cell Proteins in Biopharmaceuticals

Studying the Protein-Protein Interactions Using Surface Plasmon Interaction

How Data Analytics Brings Value to Biopharmaceutical Development and Manufacturing

CRO Panel Discussion

Implementing HCP-MS to Achieve Better Host Cell Protein Detection

NMR Characterization of the Structure and Comparability of Protein/Peptide Biologics

Process Analytical Technologies (PAT) in Biologics Manufacturing Industry

Capillary Electrophoresis - Mass Spectrometry: Transforming Biotherapeutics Quality Assessment

Use of Near Infrared Spectroscopy based PAT systems for Monitoring of Powder Blending

Current Status of QbD and PAT Implementation

Digital Transformation – Importance, opportunities and challenges

Risk Analysis and Design of Experiments (DoE) in Product Development

Enhancing organizational impact through data and digital transformation

Panel Discussion: Advancing digital CX to thrive in new normal

How can nutrition industry shape consumer behaviour?

Growing Momentum of Biosimilars and USFDA Regulations

Panel Discussion – Digital Transformation: Technology, talent and support needed to succeed

The synergy between digital strategy and customer experience strategy

Updates on USP <665>/<1665>: Chemical Characterization of Single-Use and Multi-Use Manufacturing Components

Panel Discussion: Mitigating the Gap between Industry and Academia

ICH Q3E Impurity Guideline: Assessment and Control of Extractables and Leachables for Pharmaceuticals and Biologics

Safety Evaluation on Extractables and Leachables

Analytical Updates and Sample Preparation in Extractable and Leachable Profiling Types of Impurities

Using GC & LC Orbitrap Mass Spectrometry to Confidently Identify Leached Packaging and Process Impurities

Extractables and Leachables: Regulations and Strategies for OINDPs

PQRI Best Practices: Use of a Classification Strategy to Develop Safety Thresholds

The Use of Solid Phase Micro Extraction (SPME) in E&L Studies

Importance of Accurate Chemical Characterization of Medical Devices

Challenges in Leachable Method Development and Validation

Toxicological Risk Assessment for E&L compounds

UK Regulatory Environment Now and into the Future Including Brexit and Pandemic

Development of a Drug Product workflow for Nitrosamine Risk Assessments

Evaluation and Safety Assessment of Extractables and Leachables in Biopharma (Biologics and Vaccines)

PAT Based Approach for the Development of Crystallization Processes

On Demand for New Process Analytical Technologies Applied to Injectable Drug Products

Drug Device Combinations – Evolving Regulatory Landscape

Are your materials ready for use as primary packaging and medical devices?

A Framework for Understanding Leachables Risk Management

Challenges and Recommendations in Implementing QbD in Development of Biological Products

Panel Discussion: Current Regulatory Requirements in Brazil, Mexico and CARICOM

Addressing Roadblocks During Technology Transfer

Pharmacopeial Perspective on Continuous Manufacturing

QbD-PAT in Continuous Manufacturing (CM) for Cost Optimization and Better Quality of Drug Product

Exploring the significant connection between gut health & immunity, understand how products with smart solutions can successfully captivate on the opportunity?

Indian Pharma Industry and Changing Dynamics of Regulatory Affairs

Process Validation Strategy: Traditional Process Validation or Continuous Process Verification (CPV), based on Data Rich Environment of PAT-enabled Continuous Manufacturing (CM)

Advancements on Nutrition & Food Fortification

PANEL: Analyse the significance of essential minerals, vitamins & micronutrients in contemporary diets, explore why FMCGs should incorporate it in fast moving snacking & packaged foods?

Understanding the impact of HFSS - Changing food environment over the years

PANEL: Critically examining why immunity is important today than ever before, understand how FMCG & nutrition industry can play a role in reframing consumer choices?

PANEL: How to effectively combine ‘Nature & Science’ in your existing & new product formulations to effectively upgrade your product’s performance for the current immunity & nutrition requirements?

Biosimilars in Europe: Regulation, Pricing and Policy

PANEL : Understanding Evidence Based Nutrition, exploring smart strategies to effectively utilize research around food fortification to assess & improve nutritional product performance?

"FenuLean®: A nutritional powerhouse - from appetite supression to gut health"

Examining trends around personalised nutrition & advanced nutraceuticals, understand how nutrition industry can help building longevity & quality life?

Understanding the impact of lifestyle & cardio-metabolic conditions on immunity, explore how advanced supplementation can help in moderating the health severities?

GPRS Kick-off: Strategies for Investigators Operations: Pandemic Update from the Regulatory Affairs Stand Point

Exploring the evolving consumer base & impact of conscious consumerism, understand how can nutrition industry captivate on the situation by staying ahead of consumer demands?

cGMP Inspections Amid COVID-19 Pandemic

The Art of Filing NDA/ANDA and Biologics License Application (BLA) and Post-Approval Changes to the FDA

Panel Discussion: New Political Landscape – How Will it Impact the Pharmaceutical Regulatory Environment?

Evolving FDA Quality Assessment for Small Molecule Human Drug Products

GMP Update 2021 and Outlook 2022 – Current Trends and Developments in UK and EU

Regulation of Pharmaceutical and Bio-pharmaceutical Products in Brazil

Panel Discussion: Evolving Regulatory Expectations for Emerging Market Approvals

Regulatory Updates and Amendment of the Pharma Regulations in Japan

The Current Regulatory Landscape for Continuous Manufacturing

Workshop: eCTD Preparation and Submission

Workshop: Nitrosamine and Regulatory Affairs